Nurix stock price target raised to $33 by RBC on partnership outlook
AI Summary
RBC has raised the stock price target for Nurix to $33, reflecting optimism about the company's partnership outlook. This Cyprus-based financial update concerns stock market and deal activity in the biotechnology sector.